Financhill
Back

Dr Reddy's Laboratories 10K Form

Sell
45

RDY
Dr Reddy's Laboratories

Last Price:
$15.20
Seasonality Move:
2.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RDY News And Ratings

See the #1 stock for the next 7 days that we like better than RDY

RDY Financial Statistics

Sales & Book Value

Annual Sales: $3.9B
Cash Flow: $127.1M
Price / Cash Flow: 88.37
Annual Sales: $4.68
Price / Book: 3.22

Profitability

EPS (TTM): 0.65700
Net Income (TTM): $668M
Gross Margin: $2.3B
Return on Equity: 18.27%
Return on Assets: 12.58%

Dr Reddy's Laboratories Earnings Forecast

Key Dr Reddy's Laboratories Financial Ratios

  • The Gross Profit Margin over the past 25 years for RDY is 58.50%.
  • The Selling, General & Administrative Expenses for RDY have been equal to 28.84% of Gross Profit Margin.
  • The Research & Development expenses have been 8.41% of Revenue.
  • The Interest Expense is 5.00% of Operating Income.
  • The Net Earning history of RDY is 17.37% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 14 years.

Dr Reddy's Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RDY
CUSIP: 256135
Website: drreddys.com

Debt

Debt-to-Equity Ratio: 0.13
Current Ratio: 1.92
Quick Ratio: 1.29

Price-to-Earnings

Trailing P/E Ratio: 18.81
Forward P/E Ratio: 23.18

RDY Technical Analysis vs Fundamental Analysis

Sell
45
Dr Reddy's Laboratories (RDY) is a Sell

Is Dr Reddy's Laboratories a Buy or a Sell?